Dissociation of hemoglobin accumulation and commitment during murine erythroleukemia cell differentiation by treatment with imidazole.
The effect of imidazole on DMSO-induced murine erythroleukemia (MEL) cell differentiation has been examined. While imidazole does inhibit heme, globin mRNA, and hemoglobin accumulation in DMSO-induced MEL cells, it does not affect the commitment of MEL cells to the specific limitation of proliferative capacity associated with the in vitro differentiation program. Furthermore, imidazole treatment does not affect DMSO-induced changes in cell volume, in the relative proportion of nuclear protein IP25, and in the specific activity of the enzyme cytidine deaminase. A clonal analysis in the presence of imidazole indicated that the drug prevents heme accumulation even in MEL cells already committed to terminal differentiation. These observations suggest that imidazole effectively dissociates two aspects of the erythroid differentiation program of MEL cells: globin gene expression and commitment to loss of proliferative capacity.
D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects*; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002868:Chromosomal Proteins, Non-Histone / Q000378:metabolism; D003564:Cytidine Deaminase / Q000378:metabolism; D004121:Dimethyl Sulfoxide / Q000037:antagonists & inhibitors; D004920:Erythropoiesis / Q000187:drug effects*; D005786:Gene Expression Regulation; D005914:Globins / Q000235:genetics; D006418:Heme / Q000378:metabolism; D006454:Hemoglobins / Q000096:biosynthesis*; D007093:Imidazoles / Q000494:pharmacology*; D004915:Leukemia, Erythroblastic, Acute / Q000473:pathology*; D051379:Mice; D009374:Neoplasms, Experimental / Q000473:pathology
D002868:Chromosomal Proteins, Non-Histone; D006454:Hemoglobins; D007093:Imidazoles; D006418:Heme; D005914:Globins; D003564:Cytidine Deaminase; D004121:Dimethyl Sulfoxide